Renishaw Diagnostics has launched first research use only (RUO) multiplex assay system which allows precious research samples to be 'screened' for 10 or more 'targets', from a single sample.
The RenDx RUO multiplex assay system is a platform that allows researchers to generate rapid, multiplex screens for their own targets of interest.
Using patented technologies and supported by a team of field- and laboratory-based application specialists, the RenDx RUO system can be configured to support customers own individual research.
The 3-stage process utilizes established extraction and amplification platforms and is fully compatible with standard laboratory techniques and equipment, making high sensitivity multiplex detection simple and seamless.
The RenDx(TM) RUO system has 3 components: a reagents kit which contains the materials required to process 100 assays, and a purpose-built robotic sample processor with a simple touch screen interface, designed to allow user-free operation while performing the RenDx assays.
The third component is an analyzer utilizing a highly sensitive form of spectroscopy known as surface enhanced resonance Raman scattering (SERRS) which performs multiplex detection and automated analysis of a wide range of samples with a high degree of sensitivity and specificity.
Marketing head Jim Greaves said the RUO product launch is a truly transformative technology introduction, in advance of our fully regulated RenDx platform for human diagnostics that is in advanced stages of development.
"We have presented the results of some of our research with collaboration partners at a number of scientific conferences worldwide and received excellent feedback from healthcare providers," Greaves said.